Hilde Windels
Chairman bij CELYAD ONCOLOGY SA
Vermogen: - $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Rudi Mariën | M | 79 |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019.
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | 12 jaar |
Michel Lussier | M | 67 | 17 jaar | |
Eric Soyer | M | 57 | 1 jaar | |
Herman Verrelst | M | 51 | 7 jaar | |
Koen Dejonckheere | M | 55 | 16 jaar | |
Kristof Vande Capelle | M | 55 | 17 jaar | |
Christian Reinaudo | M | 70 | 6 jaar | |
Jan Pensaert | M | 53 |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | 10 jaar |
Jan-Willem Hoste | M | - |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | 5 jaar |
Regine Slagmulder | M | 58 | 4 jaar | |
Edmond Bastijns | M | 51 | 24 jaar | |
Vincent van Bueren | M | - | 14 jaar | |
Johan Deschuyffeleer | M | 66 | 6 jaar | |
Vincent Usache | M | - |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | 11 jaar |
Donnie Hardison | M | 74 | 3 jaar | |
Wouter Laroy | M | - |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | 18 jaar |
Hilde Laga | M | 68 | 9 jaar | |
Lieve Verplancke | M | 65 | 7 jaar | |
David Georges | M | - | 5 jaar | |
Dominic Piscitelli | M | 50 | 4 jaar | |
Manon Janssen | F | 63 | 7 jaar | |
Renate Degrave | M | - | 9 jaar | |
Frank Verhaegen | M | 64 | 7 jaar | |
Robert Sebbag | M | 73 | 1 jaar | |
Joseph Sollee | M | 60 | 21 jaar | |
Eric Jean Marie Leire | M | 66 | 1 jaar | |
Philippe Archinard | M | 63 | 1 jaar | |
Michael K. McGarrity | M | 62 | 5 jaar | |
Pieter Alliet | M | - | 3 jaar | |
Luc Missorten | M | 69 | 10 jaar | |
Ann-Christine Sundell | F | 60 | 6 jaar | |
Martine George | M | 76 | 1 jaar | |
Koen Hoffman | M | 56 | 6 jaar | |
An Vermeersch | F | 53 | 7 jaar | |
Luc Gijsens | M | 71 | 6 jaar | |
Annemiek Bessaoudi | F | - | - | |
Karine Charton | M | - | 1 jaar | |
Leila Nicolas | F | - | 1 jaar | |
Pascal Birman | M | - | 1 jaar | |
Jan Desmeth | M | - | - | |
Michel Baijot | M | - |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | - |
Marina Udier | M | - | 13 jaar | |
Hugues Wallemacq | M | - |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | - |
Eytan Breman | M | - | 9 jaar | |
Frédérique Vieville | F | - | 1 jaar | |
Anne-Cécile Fumey | F | - | 1 jaar | |
Mieke van Acker | F | - |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | 6 jaar |
Marcel van Kasteel | M | - |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | - |
Kenny Cassiers | M | - | 24 jaar | |
Harry Rentrop | M | - | - | |
Marleen Johanna Limbourg | M | - |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | 6 jaar |
Miriam Reyes | F | - | - | |
Sage Mandel | F | - | - | |
Lieven de Smedt | M | - |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | 4 jaar |
Rudi de Winter | M | 63 |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | - |
Brigitte Boone | F | 64 | 9 jaar | |
John Bellano | M | 56 | 5 jaar | |
Gil Beyen | M | 62 | 1 jaar | |
Els de Cock | F | 47 | 20 jaar | |
Luc Osselaer | M | 60 |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | - |
Jonathan Wolfson | M | 53 |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | 4 jaar |
Serge Goblet | M | - | 16 jaar | |
Céline Breda | F | 54 | 1 jaar | |
Susy Spruyt | F | 56 | 9 jaar | |
Michael Krel | M | - |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | - |
Didier Hoch | M | 68 | 1 jaar | |
Jonathan M. James | M | - | - | |
Chris de Jonghe | M | - |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | - |
Jean Philippe Richard | M | - |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | - |
Geert Peeters | M | 58 | 8 jaar | |
Jérôme Bailly | M | 45 | 1 jaar | |
Marc Descheemaecker | M | 69 | 10 jaar | |
Anne Colonna | F | - |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Wim Goemaere | M | - |
Katholieke Universiteit Leuven
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | 1 jaar |
Rudi Pauwels | M | 65 | 11 jaar | |
Edwin Moses | M | 69 | 14 jaar | |
Jan Groen | M | 65 | 9 jaar | |
Patrick Jeanmart | M | 51 | 11 jaar | |
Christian Homsy | M | 65 | 12 jaar | |
Hilde Eylenbosch | M | 61 | 3 jaar | |
Bo Jesper Hansen | M | 66 | 5 jaar | |
Peter John Fellner | M | 80 | 5 jaar | |
Filippo Petti | M | 52 | 4 jaar | |
Maria Koehler | M | 67 | - | |
Margo Roberts | M | 69 | 2 jaar | |
Piet Houwen | M | 57 | - | |
Georges Rawadi | M | - | - | |
Frederic Lehmann | M | 60 | 7 jaar | |
Mark Shaffar | M | 71 | 3 jaar | |
Kurt Schmidt | M | - | 3 jaar | |
Catherine Moukheibir | F | 64 | 5 jaar | |
Greg Parekh | M | - | 2 jaar | |
Peter Piot | M | 76 | 4 jaar | |
Renaat Berckmoes | M | 59 | 3 jaar | |
Roald Borré | M | 52 |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | 9 jaar |
Chang Qi Wu | M | 69 |
Katholieke Universiteit Leuven
| 6 jaar |
Harry Glorikian | M | 58 | 2 jaar | |
Gerrit Franciscus Landolt | M | 60 |
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | 18 jaar |
Sara Zelkovic | F | - | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
België | 79 | 79.80% |
Frankrijk | 20 | 20.20% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Hilde Windels
- Persoonlijk netwerk